Segaran P. Pillai

United States Food and Drug Administration — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index1.9kcitations86works1.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bacillus and Francisella bacterial research(27), Bacteriophages and microbial interactions(14), Yersinia bacterium, plague, ectoparasites research(7), Toxin Mechanisms and Immunotoxins(7), Antibiotic Resistance in Bacteria(6)

Publications86 total

Application of multi-criteria decision analysis techniques and decision support framework for informing arbovirus risk assessments for planning, preparedness and response
Frontiers in Bioengineering and Biotechnology·2025Open Access
Mars Sample Return Sample Receiving Project Measurement Definition Team Final Report
Astrobiology·2025· 2 citedOpen Access
A framework for personal protective equipment use in laboratories: regulatory compliance and employee protection
Frontiers in Public Health·2025Open Access
Laboratory quality management system fundamentals
Frontiers in Bioengineering and Biotechnology·2025· 2 citedOpen Access
Comprehensive Growth Analysis to Detect Optimal Time Point for Carotenoid Production: A Comparative Study in Spirulina subsalsa and Chlorella pyrenoidosa
Brazilian Archives of Biology and Technology·2025Open Access
Evaluation of an Electrochemiluminescence Assay for the Rapid Detection of Ricin Toxin
Health Security·2024· 1 cited
Real-time PCR assays that detect genes for botulinum neurotoxin A–G subtypes
Frontiers in Microbiology·2024· 7 citedOpen Access
Editorial: Insights in biosafety and biosecurity 2022/2023: novel developments, current challenges, and future perspectives
Frontiers in Bioengineering and Biotechnology·2024· 1 citedOpen Access
Application of multi-criteria decision analysis techniques and decision support framework for informing plant select agent designation and decision making
Frontiers in Bioengineering and Biotechnology·2023· 2 citedOpen Access
<i>Enterobacterales</i> draft genome sequences: 15 historical (1998–2004) and 30 contemporary (2015–2016) clinical isolates from Pakistan
Microbiology Resource Announcements·2023Open Access
Investigation of multidrug-resistant plasmids from carbapenemase-producing Klebsiella pneumoniae clinical isolates from Pakistan
Frontiers in Microbiology·2023· 8 citedOpen Access
Application of multi-criteria decision analysis techniques and decision support framework for informing select agent designation for agricultural animal pathogens
Frontiers in Bioengineering and Biotechnology·2023· 5 citedOpen Access
Editorial: Insights in biosafety and biosecurity 2022: Novel developments, current challenges, and future perspectives
Frontiers in Bioengineering and Biotechnology·2023· 6 citedOpen Access
Editorial: Biosafety and Biosecurity Approaches to Counter SARS-CoV-2: From Detection to Best Practices and Risk Assessment Volume 2
Frontiers in Bioengineering and Biotechnology·2023Open Access
Practical considerations for laboratories: Implementing a holistic quality management system
Frontiers in Bioengineering and Biotechnology·2022· 12 citedOpen Access
The development and use of decision support framework for informing selection of select agent toxins with modelling studies to inform permissible toxin amounts
Frontiers in Bioengineering and Biotechnology·2022· 9 citedOpen Access
Application of Multi-Criteria Decision Analysis Techniques for Informing Select Agent Designation and Decision Making
Frontiers in Bioengineering and Biotechnology·2022· 14 citedOpen Access
Rapid Capsular Antigen Immunoassay for Diagnosis of Inhalational Anthrax: Preclinical Studies and Evaluation in a Nonhuman Primate Model
mBio·2022· 2 citedOpen Access
Validation of a Lateral Flow Test for the Presumptive Identification of the Presence of <i>Burkholderia mallei</i> or <i>Burkholderia pseudomallei</i> in Environmental Samples
Health Security·2022· 1 cited
Rapid Presumptive Identification of <i>Burkholderia mallei</i> and <i>Burkholderia pseudomallei</i> Clinical Isolates Using a Highly Specific Lateral Flow Assay
Health Security·2022· 1 cited
page 1 of 5Next →

Frequent Co-authors

David R. Hodge(19), Stephen Morse(12), Kevin Anderson(11), Lester A. Mitscher(10), Delbert M. Shankel(10), Christine A. Pillai(7), Jeannine M. Petersen(7), Cheryl R. Kuske(7), Jean F. Challacombe(7), Linda M. Weigel(6), Shashi K. Sharma(5), Sanjay Menon(5), Kristin Prentice(5), Jason G. Ramage(5), Molly A. Hughes(4), Larry H. Stanker(4), Shashi Sharma(4), Julie R. Avila(4), David Sue(4), Sara Lomonaco(3)